These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 953308)

  • 1. [Enhancement of the immune response following immunization with L1210 cells preliminarily incubated with interferon].
    Skurkovich SV; Kalinina IA; Eremkina EI; Bulycheva TI
    Biull Eksp Biol Med; 1976 Jun; 81(6):706-7. PubMed ID: 953308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intensification of cellular immune response by immunization of mice with the cells preincubated in interferon].
    Skurkovich SV; Ol'shanskaia NV; Eremkina EI
    Biull Eksp Biol Med; 1976 Oct; 82(10):1230-2. PubMed ID: 1029509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increase in the sensitivity of leukemia cells, incubated in interferon, to the effect of immune serum].
    Skurkovich SV; Kalinina IA; Eremkina EI; Bulycheva TI
    Biull Eksp Biol Med; 1976 Dec; 82(12):1459-61. PubMed ID: 1023976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stimulation of humoral immunity to surface antigens of leukemia cells using interferon-containing sera].
    Skurkovich SV; Klinova EG; Eremkina EI
    Biull Eksp Biol Med; 1976 Mar; 81(3):358-60. PubMed ID: 953286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of sera obtained by hyperimmunizing rabbits with interferon from mouse L cells.
    Kisielow B; Inglot AD; Chudzio T
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):37-44. PubMed ID: 444043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of antibodies against ML antigen in the xenogeneic host.
    Radzikowski C; Zak-Nejmark T; Wysocka M; Steuden J
    Arch Immunol Ther Exp (Warsz); 1977; 25(4):507-13. PubMed ID: 931552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA; Mitchell MS
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
    Fuji H; Mihich E
    Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-induced killing in vivo of L1210/MTX-R cells quantitated in passively immunized mice with 131I-iododeoxyuridine-labeled cells and whole-body measurement of retained radioactivity.
    Carlson GA; Terres G
    J Immunol; 1976 Sep; 117(3):822-9. PubMed ID: 956654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L 1210 cells and their position in the cell cycle.
    Killander D; Lindahl P; Lundin L; Leary P; Gresser I
    Eur J Immunol; 1976 Jan; 6(1):56-9. PubMed ID: 971720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenicity of leukemic cells during low-temperature freezing with different cryoprotectors].
    Bulycheva TI; Smolina NV; Kalinina IA; Ol'shanskaia NV
    Biull Eksp Biol Med; 1982 Dec; 94(12):75-7. PubMed ID: 6960935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
    Bowlin TL; Prakash NJ; Edwards ML; Sjoerdsma A
    Cancer Res; 1991 Jan; 51(1):62-6. PubMed ID: 1988107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of OK-432 on immunization with mitomycin-C-treated L1210 cells.
    Ryoyama K; Murayama T; Koshimura S
    Gan; 1979 Feb; 70(1):75-82. PubMed ID: 376388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of interferon induced by purified protein derivative of tuberculin in mice sensitized with BCG or cell-wall skeleton of BCG.
    Takeyama H; Kawashima K; Yamada K; Ito Y
    Gan; 1979 Aug; 70(4):421-8. PubMed ID: 389726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.